Walleye Trading
DNA.WS

Walleye Trading’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Walleye Trading’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156,312
Closed -$4.41K – 4735
2024
Q2 		$4.41K Hold
156,312
– – ﹤0.01% 3982
2024
Q1 		$14.1K Hold
156,312
– – ﹤0.01% 4261
2023
Q4 		$16.5K Hold
156,312
– – ﹤0.01% 4537
2023
Q3 		$35.2K Buy
156,312
+3,852
+3% +$1.03K ﹤0.01% 4290
2023
Q2 		$40K Buy
152,460
+105,120
+222% +$20.5K ﹤0.01% 4001
2023
Q1 		$8.52K Hold
47,340
– – ﹤0.01% 4397
2022
Q4 		$9.47K Buy
+47,340
New +$20.3K ﹤0.01% 4485
2021
Q4 		– Sell
-18,054
Closed -$61K – 6011
2021
Q3 		$61K Buy
+18,054
New +$64.3K ﹤0.01% 4581

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Walleye Trading's DNA.WS Position: Q3 2024 in Review

Walleye Trading sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 156,312 shares — an estimated $4.41K sold.

Walleye Trading first reported a position in DNA.WS in Q3 2021 and held it in 8 quarters. The position peaked at $61K in Q3 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Walleye Trading reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 156,312 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $4.41K.
  • Walleye Trading first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 8 quarters.
  • Walleye Trading's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $61K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.